Repeated treatment with chimeric anti‐CD4 antibody in multiple sclerosis

Annals of Neurology

Volumn 36, Issue 2, 1994, Pages 183-189

  Lindsey, R J W ^a   Hodgkinson, S ^a   Mehta, R ^a   Mitchell, D ^a   Enzmann, D ^a   Steinman, L ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OKT 4;

ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG HYPERSENSITIVITY; FATIGUE; FEMALE; HEADACHE; HELPER CELL; HUMAN; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; MULTIPLE SCLEROSIS; MYALGIA; NAUSEA; PRIORITY JOURNAL; PRURITUS; SYNCOPE;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; MIDDLE AGE; MULTIPLE SCLEROSIS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028024182     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410360210     Document Type: Article

References (37)

1. Multiple sclerosis
2. T‐cells in multiple sclerosis and inflammatory central nervous system diseases
3. A double‐blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects
4. Intensive immunosuppression in progressive multiple sclerosis
5. Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: a randomized, double‐blinded, placebo‐controlled clinical trial
6. Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double‐blind, placebocontrolled trial
7. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1 + 2‐lymphocytes
8. Autoimmune effector cells II. Transfer of experimental allergic encephalomyelitis with a subset of T lymphocytes
9. Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells
10. Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T‐cell subset marker
11. Successful treatment of EAE in rhesus monkeys with MHC class II specific monoclonal antibodies
12. Multiple sclerosis: distribution of T cell subsets within active chronic lesions
13. Anti‐CD4 and anti‐CD2 monoclonal antibody infusions in subjects with multiple sclerosis
14. Anti‐CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells
15. Immunological effects of high dose administration of anti‐CD4 antibody in rheumatoid arthritis patients
16. Treatment of rheumatoid arthritis with monoclonal CD4 antibody M‐T151
17. Therapeutic use of monoclonal anti‐CD4 antibody in rheumatoid arthritis
18. Use of monoclonal antibodies in vivo as a therapeutic strategy for alloimmune or autoimmune reactivity: the Besancon experience
19. Immunologic responses of progressive multiple sclerosis patients treated with an anti‐T‐cell monoclonal antibody anti‐T12
20. Treatment of rheumatoid arthritis with an anti‐CD4 monoclonal antibody
21. An open trial of OKT3 in patients with multiple sclerosis
22. Phase I clinical trial of chimeric monoclonal anti‐CD4 antibody in multiple sclerosis
23. New diagnostic criteria for multiple sclerosis: guidelines for research protocols
24. Effects of isotype and Fc region on in vitro function of a mouse/human chimeric CD4 antibody
25. A working protocol to be used as a guideline for trials in multiple sclerosis
26. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS)
27. MR imaging in multiple sclerosis: comparison with clinical, CSF, and visual evoked potential findings
28. Use of a chimeric monoclonal anti‐CD4 antibody in patients with refractory rheumatoid arthritis
29. Observations on the effect of chimeric anti‐CD4 monoclonal antibody in patients with mycosis fungoides
30. Humanised monoclonal antibody therapy for rheumatoid arthritis
31. Early T lymphocytes: differentiation in vivo of adult intrathymic precursor cells
32. A single stem cell can recolonize an embryonic thymus, producing phenotypically distinct T‐cell populations
33. T‐cell lineages, repertoire selection and tolerance induction
34. Developmental status and reconstitution potential of subpopulations of murine thymocytes
35. Cell traffic in the adult thymus: cell entry and exit, cell birth and death
36. Differential recovery of circulating T cell subsets after nodal irradiation for Hodgkin's disease
37. Effect of total lymphoid irradiation on functional status in chronic multiple sclerosis: importance of lymphopenia early after treatment—the pros